Hana Jaffar Al Khabbaz

Assessment of the Post-Marketing “Drug Ineffective” Reports Received by the Saudi Vigilance System

Hana Jaffar Al Khabbaz, Talal A. Alsoaiby & Rayan I. Alolayet · Journal of Pharmaceutical Research International · 2023

Aim: Drug Ineffective (DI) reports are Adverse Drug Events (ADE) important for post-marketing surveillance (PMS).  Currently drug safety information from the DI reports received by the Saudi Food and Drug Authority (SFDA) via the Saudi Vigilance System (SVS) is undetermined. The...

Open access Research Article 10.9734/jpri/2023/v35i307461

Healthcare Professionals' Knowledge, Attitude and Perception toward Adverse Drug Reaction Reporting in Saudi Arabia: A Systematic Review

Hana Jaffar Al Khabbaz · Journal of Pharmaceutical Research International · 2023

Aims: To systematically evaluate the currently available evidences about the knowledge, attitude and perceptions of healthcare professionals in Saudi Arabia towards reporting adverse drug reactions to the Saudi Food and Drug Authority (Saudi FDA) as the regulatory authority monit...

Open access Research Article 10.9734/jpri/2023/v35i287448